278 related articles for article (PubMed ID: 29046984)
1. Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning.
Sidelsky S; Setia S; Vourganti S
Curr Urol Rep; 2017 Oct; 18(12):93. PubMed ID: 29046984
[TBL] [Abstract][Full Text] [Related]
2. MR-guided biopsy and focal therapy: new options for prostate cancer management.
Elkhoury FF; Simopoulos DN; Marks LS
Curr Opin Urol; 2018 Mar; 28(2):93-101. PubMed ID: 29232269
[TBL] [Abstract][Full Text] [Related]
3. Targeted prostate biopsy and MR-guided therapy for prostate cancer.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Abdom Radiol (NY); 2016 May; 41(5):877-88. PubMed ID: 26907717
[TBL] [Abstract][Full Text] [Related]
4. MR-Guided Prostate Interventions.
Woodrum DA; Gorny KR; Mynderse LA
Top Magn Reson Imaging; 2018 Jun; 27(3):141-151. PubMed ID: 29870466
[TBL] [Abstract][Full Text] [Related]
5. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
6. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS
Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102
[TBL] [Abstract][Full Text] [Related]
7. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance.
Natarajan S; Jones TA; Priester AM; Geoghegan R; Lieu P; Delfin M; Felker E; Margolis DJA; Sisk A; Pantuck A; Grundfest W; Marks LS
J Urol; 2017 Oct; 198(4):839-847. PubMed ID: 28396184
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
[TBL] [Abstract][Full Text] [Related]
9. [MRI of the prostate].
Nörenberg D; Solyanik O; Schlenker B; Magistro G; Ertl-Wagner B; Clevert DA; Stief C; Reiser MF; D'Anastasi M
Urologe A; 2017 May; 56(5):665-677. PubMed ID: 28424829
[TBL] [Abstract][Full Text] [Related]
10. Central zone lesions on magnetic resonance imaging: Should we be concerned?
Tan WP; Mazzone A; Shors S; Antoine N; Ekbal S; Khare N; McKiel C; Pessis D; Deane L
Urol Oncol; 2017 Jan; 35(1):31.e7-31.e12. PubMed ID: 27692837
[TBL] [Abstract][Full Text] [Related]
11. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer.
Verma S; Choyke PL; Eberhardt SC; Oto A; Tempany CM; Turkbey B; Rosenkrantz AB
Radiology; 2017 Nov; 285(2):343-356. PubMed ID: 29045233
[TBL] [Abstract][Full Text] [Related]
12. MR Imaging-Targeted Prostate Biopsies.
Sarkar S; Verma S
Radiol Clin North Am; 2018 Mar; 56(2):289-300. PubMed ID: 29420983
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.
Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH
Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218
[TBL] [Abstract][Full Text] [Related]
14. MR Imaging-Guided Focal Treatment of Prostate Cancer: An Update.
Nour SG
Radiol Clin North Am; 2018 Mar; 56(2):301-318. PubMed ID: 29420984
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of Guided Biopsies: Fusion and Cognitive-registration Magnetic Resonance Imaging Versus Conventional Ultrasound Biopsy of the Prostate.
Oberlin DT; Casalino DD; Miller FH; Matulewicz RS; Perry KT; Nadler RB; Kundu S; Catalona WJ; Meeks JJ
Urology; 2016 Jun; 92():75-9. PubMed ID: 26966043
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer: state of the art imaging and focal treatment.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Clin Radiol; 2017 Aug; 72(8):665-679. PubMed ID: 28385253
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and magnetic resonance image response in targeted focal cryotherapy to ablate targeted biopsy-proven index lesion of prostate cancer.
Inoue Y; Ushijima S; Shiraishi T; Fujihara A; Hongo F; Ukimura O
Int J Urol; 2019 Feb; 26(2):317-319. PubMed ID: 30485553
[No Abstract] [Full Text] [Related]
18. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
[TBL] [Abstract][Full Text] [Related]
19. Current status and progress of focal therapy in Asia.
Shiraishi T; Ukimura O
Curr Opin Urol; 2018 Nov; 28(6):529-535. PubMed ID: 30102622
[TBL] [Abstract][Full Text] [Related]
20. New advances in focal therapy for early stage prostate cancer.
Tay KJ; Schulman AA; Sze C; Tsivian E; Polascik TJ
Expert Rev Anticancer Ther; 2017 Aug; 17(8):737-743. PubMed ID: 28635336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
